Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent

Dirk B. Mendel, A. Douglas Laird, Beverly D. Smolich, Robert A. Blake, Congxin Liang, Alison L. Hannah, Raymond M. Shaheen, Lee M. Ellis, Steve Weitman, Laura K. Shawver, Julie M. Cherrington

Research output: Contribution to journalReview articlepeer-review

273 Scopus citations

Fingerprint Dive into the research topics of 'Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences